Taken together, PYCR2 was highly expressed in CRC, especially in adenocarcinoma, and higher PYCR2 expression indicated a more advanced stage, increased nodal metastasis, and a poor survival rate compared to that in CRC patients with low PYCR2 expressions. This evidence concerns the gene PYCR2 and colorectal carcinoma.